TEVA PHARMACEUTICAL INDUSTRIES LTD (20) | Human Resources (14)

Browse by Subcategory

Recent Contracts

Employment Agreement, dated as of May 30, 2013, between Teva Sante and Eric Drap (Filed With SEC on February 10, 2021)
Teva Pharmaceutical Industries Limited Israeli Subplan of Tevas 2020 Long-Term Equity-Based Incentive Plan (Filed With SEC on November 5, 2020)
Separation Agreement, dated as of November 4, 2019, between Teva Pharmaceuticals USA, Inc. and Carlo de Notaristefani (Filed With SEC on February 21, 2020)
Employment Agreement, dated as of March 12, 2020, between Teva Pharmaceutical Industries Limited and Eric Drap (Filed With SEC on February 10, 2021)
Transfer Agreement of Employment Contract, dated as of March 20, 2020, between Teva Sante, Teva Pharmaceutical Industries Limited and Eric Drap (Filed With SEC on February 10, 2021)
Form Award Agreement under Tevas 2020 Long-Term Equity-Based Incentive Plan (Filed With SEC on November 5, 2020)
Amendment No. 1 dated as of June 9, 2020, to the Employment Agreement between Teva Pharmaceutical Industries Limited and Kre Schultz (Filed With SEC on June 9, 2020)
Employment Agreement, dated as of December 22, 2013, between Teva Pharmaceuticals USA Inc. and Brendan OGrady (Filed With SEC on February 21, 2020)
Employment Agreement, dated as of April 1, 2019, between Teva Pharmaceutical Industries Limited and Gianfranco Nazzi (Filed With SEC on February 21, 2020)
Employment Agreement, dated as of November 6, 2019, between Teva Pharmaceutical Industries Limited and Eli Kalif (Filed With SEC on February 21, 2020)
Form Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2016 grants and 2017 grants made to... (Filed With SEC on February 21, 2020)
Form Award Agreement (RSUs and PSUs) under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan (Filed With SEC on February 21, 2020)
Amendment to Employment Agreement between Teva Pharmaceutical Industries Limited and Eli Kalif, dated as of February 6, 2020 (Filed With SEC on February 21, 2020)
Amendment to Employment Agreement between Teva Pharmaceuticals USA, Inc. and Hafrun Fridriksdottir, dated as of January 4, 2019 (Filed With SEC on February 19, 2019)